Sartorius Stedim Biotech SA (DIM.PA)
Company Info
ISIN | FR0013154002 |
---|---|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Highlights
Market Cap | €27.25B |
---|---|
EPS | €3.36 |
PE Ratio | 83.33 |
PEG Ratio | 112.19 |
Revenue (TTM) | €2.78B |
Gross Profit (TTM) | €1.83B |
EBITDA (TTM) | €657.80M |
Year Range | €160.55 - €310.80 |
Target Price | €259.20 |
Share Price Chart
Loading data...
Compare to other instruments
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in Sartorius Stedim Biotech SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Sartorius Stedim Biotech SA had a return of 9.52% year-to-date (YTD) and -12.15% in the last 12 months. Over the past 10 years, Sartorius Stedim Biotech SA had an annualized return of 27.00%, outperforming the S&P 500 benchmark which had an annualized return of 10.96%.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 9.52% | 10.04% |
1 month | 6.45% | 3.53% |
6 months | 18.15% | 22.79% |
1 year | -12.15% | 32.16% |
5 years (annualized) | 18.31% | 13.15% |
10 years (annualized) | 27.00% | 10.96% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 4.89% | 1.23% | ||||||||||
2023 | -7.87% | -13.77% | -21.88% | 16.91% | 16.04% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for Sartorius Stedim Biotech SA (DIM.PA) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
Sartorius Stedim Biotech SA | -0.16 | ||||
S&P 500 | 2.76 |
Dividends
Dividend History
Sartorius Stedim Biotech SA granted a 0.55% dividend yield in the last twelve months. The annual payout for that period amounted to €1.44 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | €1.44 | €1.44 | €1.26 | €0.68 | €0.34 | €0.57 | €0.46 | €0.42 | €0.33 | €0.22 | €0.20 | €0.18 |
Dividend yield | 0.55% | 0.60% | 0.42% | 0.14% | 0.12% | 0.39% | 0.53% | 0.70% | 0.56% | 0.37% | 0.74% | 0.90% |
Monthly Dividends
The table displays the monthly dividend distributions for Sartorius Stedim Biotech SA. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | €0.00 | €0.00 | ||||||||||
2023 | €0.00 | €0.00 | €1.44 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2022 | €0.00 | €0.00 | €1.26 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2021 | €0.00 | €0.00 | €0.68 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2020 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.34 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2019 | €0.00 | €0.00 | €0.57 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2018 | €0.00 | €0.00 | €0.00 | €0.46 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2017 | €0.00 | €0.00 | €0.00 | €0.42 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2016 | €0.00 | €0.00 | €0.00 | €0.33 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2015 | €0.00 | €0.00 | €0.00 | €0.22 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2014 | €0.00 | €0.00 | €0.00 | €0.20 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2013 | €0.18 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Sartorius Stedim Biotech SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Sartorius Stedim Biotech SA was 76.82%, occurring on Dec 18, 2008. Recovery took 647 trading sessions.
The current Sartorius Stedim Biotech SA drawdown is 51.76%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-76.82% | Jun 19, 2007 | 377 | Dec 18, 2008 | 647 | Jun 30, 2011 | 1024 |
-74.01% | Jul 17, 1997 | 520 | Aug 19, 1999 | 330 | Dec 6, 2000 | 850 |
-71.02% | May 10, 2002 | 109 | Oct 9, 2002 | 584 | Jan 19, 2005 | 693 |
-70.21% | Sep 13, 2021 | 550 | Oct 30, 2023 | — | — | — |
-31.8% | Jul 17, 2001 | 50 | Sep 24, 2001 | 153 | May 6, 2002 | 203 |
Volatility
Volatility Chart
The current Sartorius Stedim Biotech SA volatility is 8.90%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |